A new multinational study analyzing data from over 230 million people across 20 global sites highlights the relationship ...

European researchers surveyed 28 countries and found acute flaccid myelitis (AFM) remains underreported, with only Norway maintaining dedicated surveillance. Most AFM cases coincided with years of ...

FRESNO, Calif. (KFSN) -- Turning pain into action. It's been eight years since Rob Vasquez was diagnosed with Guillain-Barré Syndrome. "It's been a long journey," said Cheryl Vasquez, Rob's wife.

What is Guillain-Barré Syndrome? Guillain-Barré Syndrome is a rare neurological disorder where the body's immune system -- which normally protects it from infections and other foreign bodies ...

Huzmeli ED, Korkmaz NC, Duman T, Gokcek O. Effects of sensory deficits on balance, functional status and trunk control in patients diagnosed with guillain-barre syndrome. Neurosciences (Riyadh).

Neuropathy, a disorder in which damage to nerves can impair sensation and movement, has many causes, including infection.

In rare cases, it can complicated by the damage of peripheral nervous system, manifesting as Guillain–Barré syndrome (GBS). Severe GBS as the initial presentation is highly infrequent and associated ...

Background Guillain-Barre syndrome (GBS) is characterized by acute onset and progressive course, and is usually associated with a good prognosis. However, there are forms of poor prognosis ...

Columbus, Ohio (WSYX) — Representative Warren Davidson, a Republican from Ohio, on Thursday introduced the Trump Derangement Syndrome (TDS) Research Act of 2025. The proposed legislation aims to ...

"And I felt for him because the way it was described to me was just post-viral syndrome, which is just lingering effects of a long illness." Porziņģis entered four of the seven Eastern ...

First Oral Presentation of the Tanruprubart Real-World Evidence (RWE) Study by International Guillain-Barré Syndrome Outcomes Study (IGOS) Researchers Highlights Benefits over Current Standard of Care ...

BRISBANE, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with ...